OHIO researcher receives more than $1 million in funding from the National Institute on Drug Abuse

berkeley_franz.jpg

Berkeley Franz, Ph.D., a researcher in Ohio University’s Heritage College of Osteopathic Medicine and the Appalachian Institute to Advance Health Equity Science (ADVANCE), was awarded over $1 million by the National Institute on Drug Abuse for two separate studies that are aimed at helping provide resources to combat the opioid epidemic.

The first study will test whether a novel training intervention can reduce the stigma surrounding a prescription drug used to treat opioid use disorder and the hesitation some health care professionals have with prescribing it. According to the Substance Abuse and Mental Health Services Administration, Buprenorphine is a narcotic used to treat pain, but it also is used to treat opioid use disorder by managing withdrawal symptoms and reducing opioid cravings. 

Close